FDAnews Drug Daily Bulletin

AstraZeneca to Acquire Chinese Generics Company

Dec. 12, 2011
A A
AstraZeneca has signed an agreement to acquire Guangdong BeiKang Pharmaceutical, a China-based generics manufacturing company.
Pharmaceutical Business Review